Ignite Creation Date:
2025-12-24 @ 4:41 PM
Ignite Modification Date:
2026-01-02 @ 5:53 AM
Study NCT ID:
NCT05288166
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-27
First Post:
2022-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-10
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-10
First Submit QC Date:
None
Study First Post Date:
2022-03-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-13
Results First Submit QC Date:
None
Results First Post Date:
2025-06-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-10
Last Update Post Date:
2025-06-27
Last Update Post Date Type:
ACTUAL